* Strong Q4 on the cards: EBIT SEK 41m (SEK -18m Q4'24) * Slightly lowered Q4 assumptions, but '26e-...
* Q4 NAV in line with ABGSCe * Strong operational performance in key private assets * P/NAV lower, d...
Finnair reports Q4 results on Feb 11. FY’25 was challenging due to labor issues, but right now the o...
Grangex löser fler och fler frågor inför starten av Sydvarangergruvan, vilket sänker risken i väntan...
* Underlying performance indicative of a brighter '26e * '26e-'27e adj.
Redeye updates on Embracer ahead of Q3-results (due 12 February) where we expect another quarter wit...
Redeye updates its estimates and valuation after Indutrade’s Q4 2025 report.
Besqab posted a record-strong Q4 with a high number of starts and strong earnings growth, with EBIT ...
* 2025 to end on a soft note * We cut '26e-'27e adj.
* Omsättning under förväntan men förbättrade marginaler * USA-närvaron stärks i flera led * Vi behål...
Suominen’s challenges continue at least in the short-term, but the company is now taking more signif...
VNV Global stänger året med en investeringsportfölj om 537,5 musd (−16,5% YoY) efter avyttringar av ...
Redeye provides its initial take on Lifco’s Q4 2025 report, which missed our projections by 3% on sa...
* Adj. EBIT 29% above estimates at SEK 47m * '26e could bring both organic and structural growth * C...
Redeye comments on Enea’s Q4 2025 report were sales fell short of expectations, yet profitability ex...
Redeye comments on Freemelt ahead of Q4 and full year results.
Smart Eye has reached a key milestone by being selected by a Japanese OEM to supply DMS software inc...
In Q4/25, we see similar trends impacting NAV as in previous quarters: listed peers trading down and...
Scanfil's guidance for 2026 indicates net sales growth of 16-31% we calculate.
Our revisions are material, as we remove the US contribution from the Zimmer Biomet deal, given that...
